Ad is loading...
AVCNF
Price
$0.17
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
PRFX
Price
$0.53
Change
+$0.01 (+1.92%)
Updated
Nov 15 closing price
Earnings call today
Ad is loading...

AVCNF vs PRFX

Header iconAVCNF vs PRFX Comparison
Open Charts AVCNF vs PRFXBanner chart's image
Avicanna
Price$0.17
Change-$0.00 (-0.00%)
Volume$12.5K
CapitalizationN/A
PainReform
Price$0.53
Change+$0.01 (+1.92%)
Volume$29.8K
CapitalizationN/A
AVCNF vs PRFX Comparison Chart
Loading...
PRFX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AVCNF vs. PRFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVCNF is a Hold and PRFX is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (AVCNF: $0.17 vs. PRFX: $0.53)
Brand notoriety: AVCNF and PRFX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AVCNF: 118% vs. PRFX: 7%
Market capitalization -- AVCNF: $18.52M vs. PRFX: $3.06M
AVCNF [@Pharmaceuticals: Other] is valued at $18.52M. PRFX’s [@Pharmaceuticals: Other] market capitalization is $3.06M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVCNF’s FA Score shows that 0 FA rating(s) are green whilePRFX’s FA Score has 0 green FA rating(s).

  • AVCNF’s FA Score: 0 green, 5 red.
  • PRFX’s FA Score: 0 green, 5 red.
According to our system of comparison, PRFX is a better buy in the long-term than AVCNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRFX’s TA Score shows that 4 TA indicator(s) are bullish.

  • PRFX’s TA Score: 4 bullish, 4 bearish.

Price Growth

AVCNF (@Pharmaceuticals: Other) experienced а -15.80% price change this week, while PRFX (@Pharmaceuticals: Other) price change was -8.80% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Reported Earning Dates

PRFX is expected to report earnings on Feb 28, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVCNF($18.5M) has a higher market cap than PRFX($3.06M). AVCNF YTD gains are higher at: -37.225 vs. PRFX (-96.783). PRFX has higher annual earnings (EBITDA): -9.57M vs. AVCNF (-13.98M). PRFX has more cash in the bank: 8.03M vs. AVCNF (222K). PRFX has less debt than AVCNF: PRFX (86K) vs AVCNF (1.81M). AVCNF has higher revenues than PRFX: AVCNF (4.18M) vs PRFX (0).
AVCNFPRFXAVCNF / PRFX
Capitalization18.5M3.06M605%
EBITDA-13.98M-9.57M146%
Gain YTD-37.225-96.78338%
P/E RatioN/A2.92-
Revenue4.18M0-
Total Cash222K8.03M3%
Total Debt1.81M86K2,102%
TECHNICAL ANALYSIS
Technical Analysis
PRFX
RSI
ODDS (%)
Bullish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
PRFX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NPK76.05-0.53
-0.69%
National Presto Industries
PLX1.40-0.01
-0.71%
Protalix BioTherapeutics
SLNO51.80-2.28
-4.22%
Soleno Therapeutics
ATR166.49-7.61
-4.37%
AptarGroup
LXEH2.20-0.19
-7.83%
Lixiang Education Holding Co Ltd

AVCNF and

Correlation & Price change

A.I.dvisor tells us that AVCNF and PRFX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCNF and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCNF
1D Price
Change %
AVCNF100%
-0.94%
PRFX - AVCNF
20%
Poorly correlated
+2.08%
ARSUF - AVCNF
12%
Poorly correlated
N/A
BSPK - AVCNF
9%
Poorly correlated
-27.31%
APNHY - AVCNF
7%
Poorly correlated
N/A
BMMJ - AVCNF
6%
Poorly correlated
-24.07%
More

PRFX and

Correlation & Price change

A.I.dvisor tells us that PRFX and AMRX have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRFX and AMRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRFX
1D Price
Change %
PRFX100%
+2.08%
AMRX - PRFX
24%
Poorly correlated
-5.89%
SUPN - PRFX
22%
Poorly correlated
-1.69%
LFCR - PRFX
21%
Poorly correlated
-4.19%
AYURF - PRFX
21%
Poorly correlated
N/A
KMDA - PRFX
21%
Poorly correlated
-0.85%
More